PUBLICATIONS · 10623706
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2000 Jan
- First author
- Middleton MR
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol 2000 Jun;18(11):2351
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- J Clin Oncol. 2000 May;18(10):2185. doi: 10.1200/JCO.2000.18.10.2185.
- note
- Source null
- related pmid
- 10811684
- relationship
- Comment in
Authors and identifiers
- name
- Middleton MR
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Aaronson N
- type
- Author
- name
- Fierlbeck G
- type
- Author
- name
- Tilgen W
- type
- Author
- name
- Seiter S
- type
- Author
- name
- Gore M
- type
- Author
- name
- Aamdal S
- type
- Author
- name
- Cebon J
- type
- Author
- name
- Coates A
- type
- Author
- name
- Dreno B
- type
- Author
- name
- Henz M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Middleton MR
- type
- Author
- name
- Grob JJ
- type
- Author
- name
- Aaronson N
- type
- Author
- name
- Fierlbeck G
- type
- Author
- name
- Tilgen W
- type
- Author
- name
- Seiter S
- type
- Author
- name
- Gore M
- type
- Author
- name
- Aamdal S
- type
- Author
- name
- Cebon J
- type
- Author
- name
- Coates A
- type
- Author
- name
- Dreno B
- type
- Author
- name
- Henz M
- type
- Author
- bibliography ids
- nci-bib-4b7f671bb6fd2674943ca104
- book metadata
- content sha256
- 51861bbc7e204628138c11f95bb8840de65725bf60d6abfeb2dfa23b94307661
- document type
- citation
- dois
- 10.1200/JCO.2000.18.1.158
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10623706
- immutable id
- pubmed:10623706@51861bbc7e204628138c11f95bb8840de65725bf60d6abfeb2dfa23b94307661
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 158-66
- volume
- 18
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol 2000 Jun;18(11):2351
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- J Clin Oncol. 2000 May;18(10):2185. doi: 10.1200/JCO.2000.18.10.2185.
- note
- Source null
- related pmid
- 10811684
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 10623706
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- 091f3e119dd82cf878e699a59462508ba94e24fc76c12bb21b1010f4d64c644d
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 2000 Jan
- precision
- month
- year
- 2000
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
Preserved source evidence · Not medical advice
Triangle